FDA Approves First Drug Shown to Slow Down Alzheimer’s Progression
The Alzheimer's drug Leqembi recently received full approval from the Food and Drug Administration (FDA), marking the first drug to...
Read moreDetailsThe Alzheimer's drug Leqembi recently received full approval from the Food and Drug Administration (FDA), marking the first drug to...
Read moreDetailsThe Eras Tour by Taylor Swift has captured the hearts of fans worldwide with her stunning performances and beloved songs....
Read moreDetailsThere are fears Australia may be headed for a recession. Some analysts say the chances are around 50-50, although the government...
Read moreDetailsRecent protests by environmental groups such as Just Stop Oil or Extinction Rebellion are getting substantial media attention – dominating...
Read moreDetailsOn Hilton Head Island, South Carolina, in a tragic incident that unfolded yesterday, a 69-year-old woman fell victim to an...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.